Moderna Stock Surges on Optimism of Bringing More Products to Market

Key TakeawaysModerna Inc. Chief Executive Officer (CEO) Stephane Bancel said Tuesday the vaccine maker expects sales to increase in 2025.Oppenheimer & Co. securities analysts upgraded the stock to "outperform," saying they expect the company will have five products on the market by 2026.Shares of Moderna, which struggled in 2023 as COVID-19 vaccine demand waned, jumped Tuesday on the news.Moderna Inc. (MRNA) shares soared 15% Tuesday as the vaccine maker got two pieces of positive news.First, Chief Executiv ...